chr19-40593167-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PVS1_SupportingPM2
The NM_003573.2(LTBP4):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,566 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003573.2 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP4 | NM_003573.2 | c.2T>C | p.Met1? | start_lost | Exon 1 of 33 | NP_003564.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP4 | ENST00000204005.13 | c.2T>C | p.Met1? | start_lost | Exon 1 of 33 | 1 | ENSP00000204005.10 | |||
LTBP4 | ENST00000600026.5 | n.2T>C | non_coding_transcript_exon_variant | Exon 1 of 5 | 3 | ENSP00000483230.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461566Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727074
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
A c.2 T>C variant of uncertain significance in the LTBP4 gene has not been published as pathogenic or been reported as benign to our knowledge, this variant alters the initiator Methionine codon. The resultant protein would be described as p.Met1?" using a question mark to signify that it is not known if the loss of Met1 means that all protein translation is completely prevented or if an abnormal protein is produced using an alternate Methionine. Of note, there are multiple transcripts of the LTBP4 gene with at least three alternative first exons, each with a different translational start site. It is not known whether loss of the Met1 translational start site in this transcript is sufficient to affect protein function, and, in the absence of functional studies, the physiological consequence of this variant cannot be precisely determined. Finally, the c.2 T>C variant is not observed in large population cohorts (Lek et al., 2016). Therefore, based on the currently available information, it is unclear if this variant is pathogenic or rare benign." -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at